NCT00644215|UnknownDMC
Loading search results
Sponsor study identifier
interventional
40
1 country
1
Study Start
June 2007
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
February 2009
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
Not reported
Date not reportedpurpose : to evaluate and compare the effectiveness and complication of 5-FU injections and MMC drop in management of early bleb failure . Design:Randomized clinical trial Methods:Patients with low injected bleb in first month after filtering or combined surgery with MMC which don't respond to high frequent topical steroids and removal of releasable sutures will be randomize to either 5-FU injection or Mitomycin drop 0.02%.For each patient slit photograph in first day of recruiting,first two weeks and first and third month will be obtained.Patients will follow for at least 3 months and IOP ,bleb configuration will check as primary outcome measures.Preoperative and postoperative data,complications,and the need for further surgical procedures will be evaluated.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
Not reported
Date not reportedClick on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
June 2007
Date type not reportedThis date has not been verified as actual or estimated.
March 24, 2008
Actual (reported)March 26, 2008
Actual (reported)February 2009
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Iop and Bleb height,extent and vascularity
At least in 3 months of follow up
complication of 5-FU injection or Mitomycin drop in treatment of early bleb failure
5-FU injection has been done
Mitomycin drop has been administrated
* 5-FU injection 5mg * Mitomycin drop 0.02%
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
labbafinejad Medical Center,Tehran-Boostan 9 St,Pasdaran Ave,
Tehran, Tehran Province, 16666, Iran
First Submitted
March 24, 2008
First Posted
March 26, 2008
Study Start
June 2007
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
February 2009
Estimated (date passed)Pro-Resolving Mediators in Acute Inflammation in Humans
Contact the study team to confirm eligibility.
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
June 17, 2008
Record last verified: 2008-06
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: